Instructions for Authors

Instructions for Authors

1. Acceptance Criteria and Types of Content

Manuscripts must show scientific significance, an original contribution, methodological rigour and relevance to the international community, and must lie within the journal's aims and scope. All manuscripts undergo double-blind peer review.

Accepted content types:

  • Original theoretical and empirical research papers
  • Case studies, analytical and simulation models
  • Review articles and literature reviews; conceptual frameworks
  • Book reviews

2. Aims, Scope and Covered Topics

  • Clinical medicine, surgery and rehabilitation – diagnosis, treatment, case reports, physiotherapy.
  • Dentistry and oral health
  • Pharmacy and pharmacology – drug utilisation, adverse reactions, pharmaco-economics, pharmaceutical formulation, medicines safety and regulation.
  • Natural products and biotechnology – bioactive compounds, antioxidant and antimicrobial activity, marine and plant sources, biomaterials, ethnobotany.
  • Public health and epidemiology – infectious disease, vaccination, antimicrobial resistance, maternal and child health, health inequalities, pandemics.
  • Health systems – management, leadership, economics, quality and patient safety, patient satisfaction.
  • Mental health and clinical psychology – clinical and psychotherapeutic research.
  • Health law, bioethics and patients’ rights
  • Environmental health and ecology
  • Medical and nursing education
  • Sport and exercise science
  • History of medicine and traditional medicine – treated in a scholarly, evidence-based way.

Outside the scope: manuscripts without a clear link to health, medicine or the natural sciences – for example finance, marketing and consumer behaviour, fashion, general organisational psychology, theology or philosophy as such, and legal or economic studies unrelated to health or the environment – are not considered.

3. Submission Requirements

  • File format: editable Microsoft Word file (.doc or .docx); PDF submissions are not accepted.
  • ORCID iD: authors, especially the corresponding author, are strongly encouraged to give their 16-digit ORCID iD.
  • Submission: through the online form https://reg.mentisia.org/press/form/. If there are technical difficulties, the manuscript may be sent to [email protected].

4. Manuscript Layout and Formatting

  • Length: up to 6,000 words including abstract, references and tables.
  • Font: Cambria, 10 pt for the body; title 12 pt bold; author details 11 pt.
  • Spacing and alignment: single-spaced and justified; 0 pt before and 6 pt after paragraphs.
  • Tables and figures: embedded in the text where discussed, in high resolution, with numbered captions; equations in an equation editor; footnotes at the bottom of the page.
  • References: American Psychological Association (APA) style; every reference must be cited in the text. Excessive self-citation and forced or unrelated citations are prohibited.

Structure:

  1. Title, author names, affiliations (with country) and corresponding e-mail
  2. Abstract (150–250 words, one paragraph) and keywords (5–10)
  3. Main body: Introduction, Literature review, Methods or model, Results, Discussion, Conclusions
  4. Declarations: conflict of interest, data availability, ethics approval and consent, generative AI
  5. References

5. Mandatory Author Declarations

These declarations go before the References.

A. Conflict of interest

Declare any financial, personal or institutional conflict of interest. If there is none: "The authors declare no conflict of interest regarding the research, authorship, or publication of this article."

B. Data availability

State how the underlying data, code or calculations can be accessed, using one of these forms:

  • "The datasets generated during this study are available in [Repository Name] at [DOI/URL]."
  • "The data that support the findings of this study are available from the corresponding author upon reasonable request."
  • "All relevant data generated or analyzed during this study are included within this published article."

C. Generative AI in writing

If generative AI or AI-assisted tools were used, include the disclosure required by the Generative AI Policy. If none were used, this section may be omitted.

D. Ethics approval and consent

Research involving human participants must state the approval of an ethics committee and confirm the informed consent of the participants (for minors, of a parent or guardian); personal identifying information must be removed. Studies on animals must state compliance with the relevant ethical standards. Clinical trials should give their registration number. Case reports require the patient’s consent.

6. Copyright, Open Access and Licensing

  • EJMN is a fully open-access journal; articles are published under CC BY-NC-SA 4.0.
  • Users may share and adapt the material for non-commercial purposes provided appropriate credit is given and adaptations are shared under the same license.
  • Authors retain copyright and grant EJMN the right of first publication.

7. Article Processing Charges (APC)

  • Amount: €220, covering double-blind review management, typesetting, DOI registration, archiving and open-access infrastructure.
  • No submission fees: there is no fee for submission or peer review.
  • Timing: the APC is invoiced only after the manuscript has passed peer review and been formally accepted. Payment details are on the invoice.

8. Publication Schedule

EJMN publishes three regular issues a year, dated 28 April, 28 August and 28 December. Accepted articles are assigned to the next open issue; late submissions may be deferred to the following one.

Journal Management

European Journal of Medicine and Natural Sciences (EJMN)
ISSN 2601-6397 (Print) | ISSN 2601-6400 (Online) | Journal e-mail: [email protected]
Publisher: Mentisia Research and Publishing (UK Company No.: 13067873)
Address: Office 1, Forest House Business Centre, 8 Gainsborough Road, London, E11 1HT, UK
Publisher e-mail: [email protected] | Phone: +44 330 027 1458